Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort studyXue Bai, Zhong‐Yi Dong, Dehua Wu et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 63
<p>Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B</p>Caixia Zheng, Xiaolu Wu, Hong‐Hong Yan et al.|Infection and Drug Resistance|2019Cited by 34